 |
|
Polymorphism and antibodies associated with highly increased risk of rheumatoid arthritis
December 22, 2005People who have a specific genetic variant of the PTPN22 gene and test positive for antibodies against cyclic citrullinated peptide are much more at risk of developing rheumatoid arthritis than people who only have one of these markers. A study published today in the journal Arthritis Research & Therapy reveals that a group of people who have a specific genetic variant, or polymorphism, of PTPN22, a gene that encodes a tyrosine phosphatase protein, and tested positive for anti-cyclic citrullinated peptide (CCP) antibodies, all developed rheumatoid arthritis (RA) in the following two and a half years. Both the polymorphism and anti-CCP antibodies have previously been shown to be associated with RA, but in combination they give a much higher risk of developing the disease than separately. This combination gives a much higher relative risk than the combination of anti-CCP antibodies and the previously well-known genetic factor, namely HLA DR4 antigens.
Martin Johansson and colleagues from the University Hospital in Umea, Sweden studied a population of 92 patients diagnosed with RA for whom a blood sample was available, which had been taken on average about two and a half years before the onset of the disease. They were matched with controls-blood donors from the same group who didn't develop arthritis-for age, sex, and rural or urban residence.
The presence of the PTPN22 1858T polymorphism was determined by genotyping and anti-CCP antibodies were detected by immunoassay of the blood samples taken two and a half years before onset of the disease.
Johansson et al.'s results confirm previous findings that RA patients are more likely to have the PTPN22 1858T polymorphism than controls. Individuals with the PTPN22 1858T polymorphism were more likely to be positive for anti-CCP antibodies, but none of the controls with the polymorphism were positive for anti-CCP antibodies. All of the blood donors who had anti-CCP antibodies and have the PTPN22 1858T polymorphism had developed RA an average of two and a half years after the blood sample was taken.
BioMed Central
Johansson et al.'s results confirm previous findings that RA patients are more likely to have the PTPN22 1858T polymorphism than controls. Individuals with the PTPN22 1858T polymorphism were more likely to be positive for anti-CCP antibodies, but none of the controls with the polymorphism were positive for anti-CCP antibodies. All of the blood donors who had anti-CCP antibodies and have the PTPN22 1858T polymorphism had developed RA an average of two and a half years after the blood sample was taken.
BioMed Central
Polymorphism Current Events and Polymorphism News RSSRight first time: Pioneering new methods of drug manufacture
Engineers at the University of Leeds have developed a simple technology which can be used in existing chemical reactors to ensure "right first time" drug crystal formation.
Genome-wide study of autism published in Nature
In one of the first studies of its kind, an international team of researchers has uncovered a single-letter change in the genetic code that is associated with autism.
Racial Disparities in Diabetes Prevalence Linked to Living Conditions
The higher incidence of diabetes among African Americans when compared to whites may have more to do with living conditions than genetics, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.
Genetic hint for ridding the body of hepatitis C
More than seventy percent of people who contract Hepatitis C will live with the virus that causes it for the rest of their lives and some will develop serious liver disease including cancer.
Diabetes advance: Researchers find gene that causes resistance to insulin
A breakthrough by an international team of researchers in Canada, France, the UK and Denmark has uncovered a new gene that could lead to better treatment of type 2 diabetes, as well as a better understanding of how this widespread disease develops.
Is endotoxin receptor CD14 rs2569190/C-159T gene correlated with chronic hepatitis C?
It is still unknown why the natural history of chronic disease caused by hepatitis C virus (HCV), which currently infects 3% of the world's population, varies from mild in some patients to rapidly progressing in others.
Common variation in gene linked to structural changes in the brain
An international group of researchers is the first to show that common variations in a gene - previously shown to be associated with Retts Syndrome, autism, and mental retardation - are associated with differences in brain structure in both healthy individuals and patients with neurological and psychiatric disorders.
New biomarker predicts response to hepatitis C treatment
Researchers have identified the first genetic marker that predicts response to hepatitis C treatments, and a single letter of DNA code appears to make a huge difference.
Comprehensive look at rare leukemia finds relatively few genetic changes launch disease
The most comprehensive analysis yet of the genome of childhood acute myeloid leukemia (AML) found only a few mistakes in the genetic blueprint, suggesting the cancer arises from just a handful of missteps.
Looking different 'helps animals to survive'
In the animal kingdom, everything is not as it seems. Individuals of the same species can look very different from each other - what biologists term 'polymorphism.'
More Polymorphism Current Events and Polymorphism News Articles
 |
Polymorphism: in the Pharmaceutical Industry by Rolf Hilfiker (Editor) Edited by one of the leading experts in the field, this handbook emphasizes why solid-state issues are important, which approaches should be taken to avoid problems and exploit the opportunities offered by solid state properties in the pharmaceutical and agricultural industries. With its practical approach, this is at once a guideline for development chemists just entering the field as well as a high-quality source of reference material for specialists in the pharmaceutical and chemical industry, structural chemists, physicochemists, crystallographers, inorganic chemists, and patent departments. |
![Polymorphism [CD on Demand]](http://ecx.images-amazon.com/images/I/61DlpofSViL._SL160_.jpg) |
Polymorphism [CD on Demand] by Stone Creed Polymorphism by Stone Creed This product is manufactured on demand using CD-R recordable media. Amazon.com's standard return policy will apply. |
 |
Polymorphism in Molecular Crystals (International Union of Crystallography) by Joel Bernstein (Author) Polymorphism--the multiplicity of structures or forms--is a term that is used in many disciplines. In chemistry it refers to the existence of more than one crystal structure for a particular chemical substance. The properties of a substance are determined by its composition and by its structure. In the last two decades, there has been a sharp rise in the interest in olymorphic systems, as an intrinsically interesting phenomenon, and as an increasingly important component in the development and marketing of a variety of materials based on organic molecule (e.g. pharmaceuticals, dyes and pigments, explosives etc). This book summarizes and brings up to date the current knowledge and understanding of polymorphism of molecular crystals, and concentrates it in one comprehensive source. The book... |
 |
Polymorphism 0.1.0 (Original Mix) Harald Klotzberg (Primary Contributor) |
 |
Polymorphism in Pharmaceutical Solids (Drugs and the Pharmaceutical Sciences) by Harry G. Brittain (Editor) Discovery Laboratories, Inc., Milford, NJ. Text providing information on the physical properties a single compound may exhibit. Presents an examination of polymorphic behavior in pharmaceutical development. For graduate students and industrial and product development pharmacists. |
 |
Polymorphism: Remembering Stockhausen by Sinfonia Electronique Sinfonia Electronique (Orchestra), Sinfonia Electronique (Orchestra), richard eppedio and c.r. keyser-posner (Orchestra), Karyl Cristoffer Jones (Orchestra) Sinfonia Electronique is an international collective of European, Asian, and North American musicians who have again come together to interpret new musical works created by its members. Once more focusing on compositions by American musicians Richard Eppedio and C.R. Keyser-Posner, and featuring performances by a select group of kindred musical spirits from various stylistic backgrounds, Sinfonia Electronique continues to move forward while maintaining a backward gaze, ever mindful of those who have come before them and blazed an amazing trail of musical mastery, leaving a legacy these performers strive to keep alive in the twenty-first century.....and beyond. Polymorphism: Remembering Stockhausen is a collection of thirteen newly-composed pieces, many infused with the spirit of... |
|
|
Polymorphism 0.2 (Original Mix) Harald Klotzberg (Primary Contributor) |
 |
Delphi CBT Pascal Video Training by Business-IQ This DVD Delphi Video series covers the Delphi programming language step-by-step, focusing on the use of Object Pascal in object-oriented programming with Delphi (Delphi OOP) . To quote one of our students, "Delphi must be the easiest programming language." How quickly you learn it is, of course, dependent on you. It is a very powerful language and mastering it will take time, depending on your background and experience. Whether you are an absolute beginner or a more seasoned Delphi developer, you will benefit from this Delphi Pascal video series. It will walk you through the Object Pascal language step-by-step. You will find enough theory to build your knowledge and understanding of the Delphi programming language. And, you will learn by doing through the multiple examples built... |
 |
Polymorphism in Pharmaceutical Solids, Second Edition (Drugs and the Pharmaceutical Sciences) by Harry G. Brittain (Editor) Using clear and practical examples, Polymorphism in Pharmaceutical Solids, Second Edition presents a complete examination of polymorphic behavior in pharmaceutical development. Ideal for pharmaceutical development scientists and graduate students in pharmaceutical science, this updated edition includes: NEW CHAPTERS - on the latest developments and methods in the field that give pharmaceutical development scientists the up-to-date information they need to successfully implement new drug development techniques and methods EXPERT EDITORSHIP - from Dr. Harry G. Brittain, whose vast experience and knowledge of the pharmaceutical industry provides readers with the authoritative advice they need and trust COMPREHENSIVE CONTENT - that includes information appropriate... |
 |
Single Nucleotide Polymorphisms: Methods and Protocols (Methods in Molecular Biology) by Pui-Yan Kwok (Editor) Univ. of California, San Francisco. Provides all the major SNP discovery and genotyping techniques in use, whether for using DNA diagnostics for identification; studying the genetic basis of human disease, or for molecular breeding programs in agriculture. Extended-outline and outline formats. |
| © 2009 BrightSurf.com |